$68.40
+1.88 (+2.83%)
USD · as of 2026-08-19 · marketstack
16 8-K filings · 8 13D · 12 13G
| Date | Event | What happened / filer | Source |
|---|---|---|---|
| 2026-08-14 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by Deep Track Capital, LP | sec.gov ↗ |
| 2026-08-10 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by Frazier Life Sciences Public Fund, L.P. | sec.gov ↗ |
| 2026-08-10 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by ORBIMED ADVISORS LLC | sec.gov ↗ |
| 2026-08-06 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-08-06 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-08-06 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2026-07-29 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc. | sec.gov ↗ |
| 2026-07-13 | 8-K 5.02 | Departure/election of directors or officers; compensation | sec.gov ↗ |
| 2026-07-08 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLP | sec.gov ↗ |
| 2026-07-08 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLC | sec.gov ↗ |
| 2026-06-24 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by Paradigm Biocapital Advisors LP | sec.gov ↗ |
| 2026-06-12 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-06-12 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-06-05 | 8-K 5.07 | Submission of matters to a vote of security holders | sec.gov ↗ |
| 2026-06-05 | 8-K 5.02 | Departure/election of directors or officers; compensation | sec.gov ↗ |
| 2026-05-11 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-05-11 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-05-07 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2026-05-06 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by FMR LLC | sec.gov ↗ |
| 2026-04-27 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc. | sec.gov ↗ |
| 2026-03-12 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2026-03-09 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-03-09 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-02-27 | 8-K 5.02 | Departure/election of directors or officers; compensation | sec.gov ↗ |
| 2026-02-27 | 8-K 1.01 | Entry into a material definitive agreement | sec.gov ↗ |
| 2026-02-11 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by ORBIMED ADVISORS LLC | sec.gov ↗ |
| 2026-02-10 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLP | sec.gov ↗ |
| 2026-02-05 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-01-22 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-01-22 | 8-K 5.02 | Departure/election of directors or officers; compensation | sec.gov ↗ |
| 2026-01-21 | 13G | Schedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc. | sec.gov ↗ |
| 2026-01-12 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2026-01-12 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2026-01-12 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2025-11-14 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by Hawryluk P. Kent | sec.gov ↗ |
| 2025-11-12 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | sec.gov ↗ |
| 2025-11-10 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by New Enterprise Associates 17, L.P. | sec.gov ↗ |
| 2025-11-06 | 8-K 5.02 | Departure/election of directors or officers; compensation | sec.gov ↗ |
| 2025-11-06 | 8-K 2.02 | Results of operations and financial condition (earnings)earnings history (EARN) → | sec.gov ↗ |
| 2025-10-06 | 13G/A | Schedule 13G amendment — ≥5% beneficial owner (passive) · by WELLINGTON MANAGEMENT GROUP LLP | sec.gov ↗ |
| 2025-09-30 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by ORBIMED ADVISORS LLC | sec.gov ↗ |
| 2025-09-30 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by Norwest Venture Partners XVI, LP | sec.gov ↗ |
| 2025-09-30 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by Frazier Life Sciences Public Fund, L.P. | sec.gov ↗ |
| 2025-09-26 | 8-K 1.01 | Entry into a material definitive agreement | sec.gov ↗ |
| 2025-09-22 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2025-09-22 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2025-09-04 | 8-K 8.01 | Other events | sec.gov ↗ |
| 2025-09-04 | 8-K 7.01 | Regulation FD disclosure | sec.gov ↗ |
| 2025-08-20 | 13D/A | Schedule 13D amendment — ≥5% beneficial owner (active intent) · by Frazier Life Sciences Public Fund, L.P. | sec.gov ↗ |
Source: SEC EDGAR (public domain) · history starts 2025-08-20
Every row is a filed document, checked against its EDGAR index.